These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. The sodium-iodine symporter and the proton-pump inhibitors in - related to the side effects of- the treatment of thyroid cancer with iodine-131. Sfakianakis G, Sfakianaki E. Hell J Nucl Med; 2007 Feb 01; 10(1):2-5. PubMed ID: 17450241 [Abstract] [Full Text] [Related]
29. [Guideline for Radioiodine Therapy for Benign Thyroid Diseases (6/2022 - AWMF No. 031-003)]. Dietlein M, Grünwald F, Schmidt M, Kreissl MC, Luster M, Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie e. V. (DGAV), Chirurgische Arbeitsgemeinschaft Endokrinologie (CAEK) der DGAV, Deutsche Gesellschaft für Chirurgie e. V. (DGCH), Deutsche Gesellschaft für Endokrinologie e. V. (DGE). Nuklearmedizin; 2024 Feb 01; 63(1):8-20. PubMed ID: 37871629 [Abstract] [Full Text] [Related]
30. Lung toxicity in radioiodine therapy of thyroid carcinoma: development of a dose-rate method and dosimetric implications of the 80-mCi rule. Sgouros G, Song H, Ladenson PW, Wahl RL. J Nucl Med; 2006 Dec 01; 47(12):1977-84. PubMed ID: 17138740 [Abstract] [Full Text] [Related]
37. Radiation Safety Precautions in (131)I Therapy of Graves' Disease Based on Actual Biokinetic Measurements. Liu B, Tian R, Peng W, He Y, Huang R, Kuang A. J Clin Endocrinol Metab; 2015 Aug 01; 100(8):2934-41. PubMed ID: 26046966 [Abstract] [Full Text] [Related]